In summary, this study investigates the overexpression of EDB-FN in human PanIN, PaCa specimens, and in murine models of PaCa, and demonstrates the effectiveness of MRMI of EDB-FN with a small molecular targeted MRI contrast agent MT218. The gene discussed is FN1; the disease is permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome.